Stock listing

MBIO Stock Price, News, Filings & Events — Mindbio Therapeutics Corp.

Selected listing: MBIO · NEO · CAD · CA

This page tracks Mindbio Therapeutics Corp.'s MBIO:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MBIO:NEO. MBIO:NEO is the stock-level entry point for investors researching Mindbio Therapeutics Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mindbio Therapeutics Corp. (Ticker: MBIO) is a public company based in Canada, focused on the development of innovative therapeutic solutions. With a market capitalization of approximately CAD 1.58 million, the company aims to advance its research and product offerings in the biotechnology sector. Mindbio is dedicated to addressing unmet medical needs through its unique approach to treatment development.

MBIO:NEOCADCAUpdated September 11, 2026
Mindbio Therapeutics Corp. logo
Ticker
MBIO:NEO
Asset type
Stock
Market cap
$1.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NEO
Currency
CAD

Mindbio Therapeutics Corp. MBIO:NEO stock context

This page tracks Mindbio Therapeutics Corp.'s MBIO:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MBIO:NEO. MBIO:NEO is the stock-level entry point for investors researching Mindbio Therapeutics Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mindbio Therapeutics Corp. (Ticker: MBIO) is a public company based in Canada, focused on the development of innovative therapeutic solutions. With a market capitalization of approximately CAD 1.58 million, the company aims to advance its research and product offerings in the biotechnology sector. Mindbio is dedicated to addressing unmet medical needs through its unique approach to treatment development.

Latest news from Mindbio Therapeutics Corp.

All Mindbio Therapeutics Corp. news →

Research Mindbio Therapeutics Corp.

Alternate listings